story of the week
J&J COVID-19 Vaccine 66 Percent Effective in Interim Analysis
Efficacy varies by region, with 57 percent efficacy in South Africa and 72 percent efficacy in the United States
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles: